African Americans with prostate cancer respond better to abiraterone than Caucasians

The androgen synthesis inhibitor abiraterone increases the survival of men with metastatic prostate cancer; however, existing clinical trials consistently over-represent Caucasian men. Here, Andrew Ar... Author: VJOncology Added: 07/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts